LunaVax

In 2017, a groundbreaking study challenged the global vaccine system.The Vaccine Manufacturing and Procurement in Africa (VMPA) study (PDF) confirmed what many already knew on the ground: Even when African countries invest in local vaccine manufacturing, they’re still being locked out of the very systems meant to deliver vaccines to their own people. Procurement barriers.

To deliver vaccines equitably, we need more than just doses — we need a system.The LunaChain offers a new model: a connected, community-powered network built to get vaccines where they’re needed most. The Access Problem Isn’t Just Supply. It’s Systems. Vaccines don’t save lives on their own—delivery does. In many parts of Africa, millions of

At LunaVax, we’re reimagining vaccine delivery — starting in Lagos and Abuja, Nigeria, with something as small as a patch. Microneedle vaccine patches (MAPs) are an emerging innovation that could help make vaccines safer, simpler, and easier to deliver — especially in communities with limited access to cold chains, trained health workers, or reliable power

Accelerating Access: LunaVax’s MAP Pilot in Nigeria At LunaVax, we believe that innovation in global health doesn’t end in the lab—it begins when breakthrough tools reach the communities that need them most. You can’t drive vaccine access without reaching the last mile. This year, we’re launching a feasibility pilot of microneedle vaccine patches (MAPs) for